Chronic portal vein thrombosis
ICD-10 I81 · ICD-11 DB98.3.2

Treatment of Chronic Portal Vein Thrombosis in Cirrhosis with Portal Hypertension Complications

This protocol covers patients with liver cirrhosis who have chronic portal vein thrombosis that has been present or persistent for more than six months, complicated by manifestations of portal hypertension — including variceal bleeding, refractory ascites, or hepatic hydrothorax.

Clinical Scenario

Liver cirrhosis with chronic portal vein thrombosis (present or persistent for >6 months) and portal hypertension complications including variceal bleeding, refractory ascites, or hepatic hydrothorax.

Treatment Approach (partial)

Guideline-supported management in this setting includes nonselective beta-blockers as first-line medical therapy. The complete structured regimen — including sequencing, additional options, and decision criteria — is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens
References
DOI: 10.1016/j.tvir.2025.101084
Chronic PVT present or persistent for >6 months.
The ACG also recommends consideration of TIPS placement in patients with PVT and sequelae of portal hypertension, including variceal bleeding, refractory ascites, and hepatic hydrothorax.
The ACG recommends the use of nonselective beta-blockers as first-line medical therapy, followed by endoscopic variceal ligation (strong recommendation, low quality of evidence).
The Baveno VII consensus statements recommend the use of beta-blockers or endoscopic therapy for primary and secondary prophylaxis of portal hypertension-related bleeding in the setting of chronic PVT, without endorsement of a single first-line therapy.
View source ↗